A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer : results of the ERASME 3 studyCASSIER, Philippe A; CHABAUD, Sylvie; AGOSTINI, Cecile et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 343-350, issn 0167-6806, 8 p.Article

Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell linesPAVILLARD, Valérie; AGOSTINI, Cécile; RICHARD, Sophie et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 4, pp 329-335, issn 0344-5704Article

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast CancerBACHELOT, Thomas; BAJARD, Agathe; FERRI-DESSENS, Rose-Marie et al.Oncology. 2011, Vol 80, Num 3-4, pp 262-268, issn 0030-2414, 7 p.Article